Etiology of the idiopathic childhood stroke remains unknown. In previous studies, the immunologic process may be involved in the idiopathic stroke. Tumor necrosis factor— alpha (TNF-α), an important immune mediator, may contribute to the initiation and progression in the stroke. The main purpose of this study was to investigate correlation of TNF-α genetic variation and idiopathic childhood ischemic stroke. Using the direct DNA sequencing method, polymorphisms in the TNF-α promoter region were genotyped in 67 Chinese patients with idiopathic childhood stroke and 70 controls. Among totally 7 single nucleotide polymorphisms identified in the TNF-α promoter region, the variant of the -863C/A is associated with increased risk of idiopathic childhood ischemic stroke in our study group. TNF-α molecule may have genetically as well as functionally an important role in the pathogenesis of idiopathic childhood ischemic stroke in the Chinese population.
Jordan LCStroke in childhood. Neurologist. 2006;12:94-102.
2.
Lynch JK, Han CJPediatric stroke: what do we know and what do we need to know? Semin Neurol. 2005;25:410-423.
3.
Barnes C., Newall F., Furmedge J., et al. Arterial ischaemic stroke in children. J Paediatr Child Health. 2004;40:384-387.
4.
Walsh LE, Garg BPIschemic strokes in children. Indian J Pediatr. 1997;64:613-623.
5.
Lanthier S., Carmant L., David M., et al. Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology. 2000;54:371-378.
6.
Steinlin M., Roellin K., Schroth G.Long-term follow-up after stroke in childhood. Eur J Pediatr . 2004;163:245-250.
7.
Harcos P., Laki J., Kiszel P., et al. Decreased frequency of the TNF2 allele of TNF-alpha -308 promoter polymorphism is associated with lacunar infarction. Cytokine . 2006;33:100-105.
8.
Grau AJ, Aulmann M., Lichy C., et al. Increased cytokine release by leucocytes in survivors of stroke at young age. Eur J Clin Invest. 2001;31:999-1006.
9.
Vila N., Castillo J., Davalos A., et al. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke. 2000;31:2325-2329.
10.
Zou LP, Guo YH, Fang F., et al. Evidence for human leukocyte antigen-related susceptibility in idiopathic childhood ischemic stroke. Eur Neurol. 2002;48:153-157.
11.
Park K., Kim N., Nam J., et al. Association of TNFA promoter region haplotype in Behcet's Disease . J Korean Med Sci. 2006;21:596-601.
12.
DeVeber G.Risk factors for childhood stroke: little folks have different strokes!Ann Neurol.2003;53:149-150.
13.
Lalouschek W., Schillinger M., Hsieh K., et al. Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events. Clin Chem Lab Med. 2006;44:918-23.
14.
Chang HK, Jang WC, Park SB, et al. The novel -G646A polymorphism of the TNF alpha promoter is associated with the HLA-B51 allele in Korean patients with Behcçet's disease. Scand J Rheumatol. 2007;36:216-221.
15.
Munthe-Kaas MC, Carlsen KL, Carlsen KH, et al. Haplotypes and the TNFA-308 polymorphism: associations with asthma and allergy. Allergy. 2007;62:991-998.
16.
Hirankarn N. , Nakkuntod J., Duangchalermwong P., et al. The association of DRB1*04 share epitope alleles and tumor necrosis factor-alpha gene polymorphism (-863) with susceptibility to rheumatoid arthritis in Thai. Rheumatol Int. 2007;28:161-165.
17.
Bayley JP, Ottenhoff TH, Verweij CLIs there a future for TNF promoter polymorphisms? Genes Immun . 2004;5:315-329.
18.
Um JY, Kim HMTumor necrosis factor alpha gene polymorphism is associated with cerebral infarction. Brain Res Mol Brain Res. 2004;122:99-102.
19.
Lee BC, Ahn SY, Doo HK, et al. Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor-alpha genes, but not the interleukin-1beta gene. Neurosci Lett. 2004;357:33-36.
20.
Karahan ZC, Deda G., Sipahi T., et al. TNF-alpha -308G/A and IL-6 -174 G/C polymorphisms in the Turkish pediatric stroke patients. Thromb Res. 2005 ;115:393-398.
21.
Hoppe C., Klitz W., D'Harlingue K., et al. Confirmation of an association between the TNF (-308) promoter polymorphism and stroke risk in children with sickle cell anemia. Stroke. 2007;38:2241-2246.
22.
Rubattu S., Speranza R., Ferrari M., et al. A role of TNF-alpha gene variant on juvenile ischemic stroke: a case-control study. Eur J Neurol. 2005;12:989-993.
23.
Yamada Y., Metoki N., Yoshida H., et al. Genetic risk for ischemic and hemorrhagic stroke. Arterioscler Thromb Vasc Biol. 2006;26:1920-1925.
24.
Kouwenhoven M., Carlstrom C., Ozenci V., et al. Matrix metalloproteinase and cytokine profiles in monocytes over the course of stroke. J Clin Immunol . 2001;21:365-375.
25.
Geng YJ, Wu Q., Muszynski M., et al. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vasc Biol. 1996;16:19-27.
26.
Castellanos M., Castillo J., García MM, et al. Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target. Stroke . 2002;33:982-987.
